Eikon Therapeutics (EIKN) vs Entera Bio (ENTX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 7, 2026.
Summary
Entera Bio is the larger company by market cap ($436.3 million vs $408.4 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | EIKN | ENTX |
|---|---|---|
| Share price | $7.54 | $2.51 |
| Market cap | $408.40M | $436.32M |
| 1-day change | +0.40% | -0.79% |
| YTD return | — | +29.38% |
| 1-year return | — | +32.80% |
| 5-year return | — | -44.47% |
| EPS (TTM) | $-8.51 | $-0.36 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $17.40 | $4.20 |
| 52-week low | $7.02 | $0.91 |
| Distance from 52-week high | -56.67% | -40.24% |
| Average volume | 486.76K | 1.81M |
| Shares outstanding | 54.17M | 173.83M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Biotechnology: Biological Products (No Diagnostic Substances) |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
EIKN vs ENTX FAQ
Which is bigger, Eikon Therapeutics or Entera Bio?
Entera Bio (ENTX) is larger, with a market capitalization of $436.32M compared with $408.40M for Eikon Therapeutics (EIKN).
Are Eikon Therapeutics and Entera Bio in the same industry?
Yes. Both are classified in the Biotechnology: Biological Products (No Diagnostic Substances) industry within the Health Care sector.